Novartis Community Update – European Huntington Association

This medicine helps the body make more of the healthy huntingtin protein and less of the harmful form that leads to disease development, which could help slow or change the course of HD.

Novartis has emphasized its commitment to transparency and to sharing updates as development continues. Anyone interested in learning more about ongoing studies or participation opportunities is encouraged to speak with their healthcare provider and consult trusted sources such as ClinicalTrials.gov.